应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BIAF bioAffinity Technologies, Inc.
盘前交易 02-10 04:04:17 EST
0.9000
+0.0488
+5.73%
最高
0.9034
最低
0.8200
成交量
14.92万
今开
0.8760
昨收
0.8512
日振幅
9.80%
总市值
404.88万
流通市值
306.13万
总股本
449.87万
成交额
12.91万
换手率
4.39%
流通股本
340.14万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Bioaffinity Technologies, Inc.盘中异动 大幅上涨5.50%报0.898美元
市场透视 · 02-09 23:02
Bioaffinity Technologies, Inc.盘中异动 大幅上涨5.50%报0.898美元
bioAffinity Technologies宣布获得美国专利申请的允许通知,涉及其肺癌诊断算法和检测方法
美股速递 · 2025-10-16
bioAffinity Technologies宣布获得美国专利申请的允许通知,涉及其肺癌诊断算法和检测方法
Wallachbeth Capital宣布bioAffinity Technologies完成180万美元普通股注册直接融资,按纳斯达克规则以市价定价
美股速递 · 2025-10-10
Wallachbeth Capital宣布bioAffinity Technologies完成180万美元普通股注册直接融资,按纳斯达克规则以市价定价
bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资,定价符合纳斯达克市场规则
美股速递 · 2025-10-09
bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资,定价符合纳斯达克市场规则
Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌7.28%报2.42美元
市场透视 · 2025-10-06
Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌7.28%报2.42美元
bioAffinity Technologies宣布进行1:30反向股票拆分,将于2025年9月19日开盘时生效
美股速递 · 2025-09-17
bioAffinity Technologies宣布进行1:30反向股票拆分,将于2025年9月19日开盘时生效
Bioaffinity Technologies, Inc.股价上涨18.33% 市值涨173.16万美元
市场透视 · 2025-09-15
Bioaffinity Technologies, Inc.股价上涨18.33% 市值涨173.16万美元
Bioaffinity Technologies, Inc.盘中异动 早盘股价大涨7.67%报0.400美元
市场透视 · 2025-03-10
Bioaffinity Technologies, Inc.盘中异动 早盘股价大涨7.67%报0.400美元
Bioaffinity Technologies, Inc.盘中异动 早盘大幅上涨5.15%报0.347美元
市场透视 · 2025-03-05
Bioaffinity Technologies, Inc.盘中异动 早盘大幅上涨5.15%报0.347美元
Bioaffinity Technologies, Inc.盘中异动 早盘急速下挫8.00%报0.460美元
市场透视 · 2025-03-03
Bioaffinity Technologies, Inc.盘中异动 早盘急速下挫8.00%报0.460美元
Bioaffinity Technologies, Inc.盘中异动 早盘大幅拉升7.12%
市场透视 · 2025-02-28
Bioaffinity Technologies, Inc.盘中异动 早盘大幅拉升7.12%
Bioaffinity Technologies, Inc.盘中异动 早盘大幅下跌8.81%报0.527美元
市场透视 · 2025-02-27
Bioaffinity Technologies, Inc.盘中异动 早盘大幅下跌8.81%报0.527美元
Bioaffinity Technologies, Inc.盘中异动 早盘急速下跌5.54%报0.614美元
市场透视 · 2025-02-26
Bioaffinity Technologies, Inc.盘中异动 早盘急速下跌5.54%报0.614美元
Bioaffinity Technologies, Inc.盘中异动 急速拉升5.45%
市场透视 · 2025-02-25
Bioaffinity Technologies, Inc.盘中异动 急速拉升5.45%
Bioaffinity Technologies, Inc.盘中异动 快速下跌6.02%
市场透视 · 2025-02-25
Bioaffinity Technologies, Inc.盘中异动 快速下跌6.02%
Bioaffinity Technologies, Inc.盘中异动 快速拉升6.37%报0.836美元
市场透视 · 2025-02-20
Bioaffinity Technologies, Inc.盘中异动 快速拉升6.37%报0.836美元
Bioaffinity Technologies, Inc.盘中异动 股价大涨5.13%
市场透视 · 2025-02-10
Bioaffinity Technologies, Inc.盘中异动 股价大涨5.13%
Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌5.95%
市场透视 · 2025-02-07
Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌5.95%
Bioaffinity Technologies, Inc.盘中异动 股价大跌5.51%
市场透视 · 2025-02-07
Bioaffinity Technologies, Inc.盘中异动 股价大跌5.51%
Bioaffinity Technologies, Inc.盘中异动 早盘快速上涨5.04%
市场透视 · 2025-02-06
Bioaffinity Technologies, Inc.盘中异动 早盘快速上涨5.04%
暂无数据
公司概况
公司名称:
bioAffinity Technologies, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
bioAffinity Technologies, Inc.于2014年3月26日在特拉华州成立。该公司专注于早期癌症和肺部疾病的无创诊断需求,并靶向癌症治疗。该公司开发了体外诊断专有平台,其第一个平台是用于早期发现肺癌的无创检测。该公司的诊断测试基于可能适用于检测其他肺部疾病如慢性阻塞性肺病(COPD)和哮喘,以及诊断前列腺癌和膀胱癌等癌症类型的平台技术。
发行价格:
--
{"stockData":{"symbol":"BIAF","market":"US","secType":"STK","nameCN":"bioAffinity Technologies, Inc.","latestPrice":0.9,"timestamp":1770670800000,"preClose":0.8512,"halted":0,"volume":149185,"delay":0,"changeRate":0.05733082706766925,"floatShares":3401400,"shares":4498700,"eps":-20.279951,"marketStatus":"盘前交易","change":0.0488,"latestTime":"02-10 04:04:17 EST","open":0.876,"high":0.903449,"low":0.82,"amount":129122.41471875,"amplitude":0.098037,"askPrice":5,"askSize":101,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.279951,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":0.9,"postHourTrading":{"tag":"盘后","latestPrice":0.8655,"preClose":0.9,"latestTime":"19:10 EST","volume":572,"amount":496.7043,"timestamp":1770682222376,"change":-0.0345,"changeRate":-0.038333,"amplitude":0.018556},"volumeRatio":0.458805},"requestUrl":"/m/hq/s/BIAF/tweets","defaultTab":"tweets","newsList":[{"id":"2610654302","title":"Bioaffinity Technologies, Inc.盘中异动 大幅上涨5.50%报0.898美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610654302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610654302?lang=zh_cn&edition=full","pubTime":"2026-02-09 23:02","pubTimestamp":1770649324,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日23时02分,Bioaffinity Technologies, Inc.股票出现波动,股价快速上涨5.50%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为1.23%。其相关个股中,Genedx Holdings Corp.、Bioaffinity Technologies, Inc.、Natera, Inc.涨幅较大,Xwell, Inc.、Ispecimen Inc.、Inotiv, Inc.较为活跃,换手率分别为91.26%、8.68%、0.88%,振幅较大的相关个股有Xwell, Inc.、Inotiv, Inc.、Ispecimen Inc.,振幅分别为31.30%、17.33%、12.97%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209230204a48fafca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209230204a48fafca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"1142229976","title":"bioAffinity Technologies宣布获得美国专利申请的允许通知,涉及其肺癌诊断算法和检测方法","url":"https://stock-news.laohu8.com/highlight/detail?id=1142229976","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142229976?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:01","pubTimestamp":1760616074,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布获得美国专利申请的允许通知,涉及其肺癌诊断算法和检测方法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BIAF","BK4139"],"gpt_icon":0},{"id":"1139703216","title":"Wallachbeth Capital宣布bioAffinity Technologies完成180万美元普通股注册直接融资,按纳斯达克规则以市价定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1139703216","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139703216?lang=zh_cn&edition=full","pubTime":"2025-10-10 02:02","pubTimestamp":1760032939,"startTime":"0","endTime":"0","summary":"Wallachbeth Capital宣布,bioAffinity Technologies已成功完成180万美元的注册直接融资交易,本次融资以普通股形式进行,定价遵循纳斯达克市场规则,采用市场价格定价机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"1129857267","title":"bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资,定价符合纳斯达克市场规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1129857267","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129857267?lang=zh_cn&edition=full","pubTime":"2025-10-09 03:47","pubTimestamp":1759952838,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc.日前宣布完成约180万美元的注册直接融资,本次融资通过发行普通股实现,股票定价按照纳斯达克市场规则执行。\n此次融资采用按市价定价的方式进行,严格遵循纳斯达克交易所的相关规定和要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"gpt_icon":0},{"id":"2573508879","title":"Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌7.28%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573508879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573508879?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:39","pubTimestamp":1759757940,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时39分,Bioaffinity Technologies, Inc.股票出现异动,股价急速跳水7.28%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为0.31%。其相关个股中,Applied Dna Sciences, Inc.、Insight Molecular Diagnostics Inc.、Bioaffinity Technologies Inc C/Wts 07/09/2027 涨幅较大,Applied Dna Sciences, Inc.、Mainz Biomed N.V.、Bioaffinity Technologies, Inc.较为活跃,换手率分别为52.42%、2.01%、1.90%,振幅较大的相关个股有Grail, Inc.、Mainz Biomed N.V.、Bioaffinity Technologies, Inc.,振幅分别为7.86%、5.78%、3.83%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213900a6aedb44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213900a6aedb44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"1116292885","title":"bioAffinity Technologies宣布进行1:30反向股票拆分,将于2025年9月19日开盘时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1116292885","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116292885?lang=zh_cn&edition=full","pubTime":"2025-09-17 20:16","pubTimestamp":1758111399,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布进行1:30反向股票拆分,将于2025年9月19日开盘时生效","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139","BIAFW"],"gpt_icon":0},{"id":"2567107243","title":"Bioaffinity Technologies, Inc.股价上涨18.33% 市值涨173.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567107243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567107243?lang=zh_cn&edition=full","pubTime":"2025-09-15 21:31","pubTimestamp":1757943074,"startTime":"0","endTime":"0","summary":"北京时间2025年09月15日21时31分,Bioaffinity Technologies, Inc.股票出现异动,股价快速上涨18.33%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为0.15%。其相关个股中,Check-Cap Ltd.、Bioaffinity Technologies, Inc.、Prophase Labs, Inc.涨幅较大,Check-Cap Ltd.、Bioaffinity Technologies, Inc.、Ispecimen Inc.较为活跃,换手率分别为1352.22%、139.56%、20.78%,振幅较大的相关个股有Check-Cap Ltd.、Ispecimen Inc.、Precipio, Inc.,振幅分别为37.54%、7.69%、4.21%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213114a4c78e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213114a4c78e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2518276192","title":"Bioaffinity Technologies, Inc.盘中异动 早盘股价大涨7.67%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276192?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:50","pubTimestamp":1741618251,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时50分,Bioaffinity Technologies, Inc.股票出现波动,股价大幅上涨7.67%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为0.23%。其相关个股中,Bioaffinity Technologies, Inc.、恩佐生化、23Andme Holding Co.涨幅较大,Ispecimen Inc.、Mainz Biomed N.V.、Grail, Inc.较为活跃,换手率分别为6.12%、2.70%、2.01%,振幅较大的相关个股有Inotiv, Inc.、23Andme Holding Co.、Exagen Inc.,振幅分别为20.23%、16.77%、15.17%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225051a26a430d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225051a26a430d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2517910702","title":"Bioaffinity Technologies, Inc.盘中异动 早盘大幅上涨5.15%报0.347美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910702?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:34","pubTimestamp":1741185287,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时34分,Bioaffinity Technologies, Inc.股票出现异动,股价快速上涨5.15%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为0.04%。其相关个股中,Neuronetics, Inc.、Radnet, Inc.、Genedx Holdings Corp.涨幅较大,Ispecimen Inc.、Endra Life Sciences Inc.、Neuronetics, Inc.较为活跃,换手率分别为0.62%、0.60%、0.51%,振幅较大的相关个股有Biodesix, Inc.、Neuronetics, Inc.、Oncocyte Corporation,振幅分别为9.15%、8.82%、6.26%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223447989d46a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223447989d46a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2516939634","title":"Bioaffinity Technologies, Inc.盘中异动 早盘急速下挫8.00%报0.460美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516939634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516939634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:35","pubTimestamp":1741012524,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时35分,Bioaffinity Technologies, Inc.股票出现异动,股价大幅下挫8.00%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为0.72%。其相关个股中,Biodesix, Inc.、Endra Life Sciences Inc.、Neuronetics, Inc.涨幅较大,23Andme Holding Co.、Prophase Labs, Inc.、Ispecimen Inc.较为活跃,换手率分别为3.35%、0.98%、0.87%,振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、安奈特保险、Biodesix, Inc.,振幅分别为20.35%、9.00%、7.30%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032235249637ad36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032235249637ad36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDSX","BIAF","BK4139","BK4196"],"gpt_icon":0},{"id":"2514373893","title":"Bioaffinity Technologies, Inc.盘中异动 早盘大幅拉升7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373893?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:52","pubTimestamp":1740754366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时52分,Bioaffinity Technologies, Inc.股票出现波动,股价大幅拉升7.12%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为0.04%。其相关个股中,Opko健康、Fulgent Genetics, Inc.、Personalis, Inc.涨幅较大,Ispecimen Inc.、Prophase Labs, Inc.、Mainz Biomed N.V.较为活跃,换手率分别为5.47%、1.84%、1.82%,振幅较大的相关个股有Personalis, Inc.、Castle Biosciences, Inc.、Fulgent Genetics, Inc.,振幅分别为13.44%、13.09%、12.27%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822524696341ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822524696341ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2514383041","title":"Bioaffinity Technologies, Inc.盘中异动 早盘大幅下跌8.81%报0.527美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514383041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514383041?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666904,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分,Bioaffinity Technologies, Inc.股票出现波动,股价急速跳水8.81%。截至发稿,该股报0.527美元/股,成交量1.254万股,换手率0.08%,振幅4.86%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为0.96%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223504a2567aea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223504a2567aea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2514385924","title":"Bioaffinity Technologies, Inc.盘中异动 早盘急速下跌5.54%报0.614美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385924?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:46","pubTimestamp":1740581208,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时46分,Bioaffinity Technologies, Inc.股票出现波动,股价快速下挫5.54%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为0.09%。其相关个股中,Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Endra Life Sciences Inc.涨幅较大,Prophase Labs, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃,换手率分别为4.71%、2.04%、1.29%,振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prophase Labs, Inc.、Bioaffinity Technologies, Inc.,振幅分别为25.74%、10.61%、9.23%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224648abddf0f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224648abddf0f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2514309037","title":"Bioaffinity Technologies, Inc.盘中异动 急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514309037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514309037?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493959,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分,Bioaffinity Technologies, Inc.股票出现异动,股价大幅上涨5.45%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为0.20%。其相关个股中,Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prenetics Global、Bioaffinity Technologies, Inc.涨幅较大,Ispecimen Inc.、Prophase Labs, Inc.、Check-Cap Ltd.较为活跃,换手率分别为16.56%、6.41%、0.90%,振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、万基遗传、Veracyte, Inc.,振幅分别为31.96%、11.25%、9.52%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522323998924ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522323998924ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2514705679","title":"Bioaffinity Technologies, Inc.盘中异动 快速下跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514705679?lang=zh_cn&edition=full","pubTime":"2025-02-25 05:00","pubTimestamp":1740430832,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日05时00分,Bioaffinity Technologies, Inc.股票出现波动,股价快速跳水6.02%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为0.58%。其相关个股中,Check-Cap Ltd.、Ispecimen Inc.、Endra Life Sciences Inc.涨幅较大,Ispecimen Inc.、Check-Cap Ltd.、Prophase Labs, Inc.较为活跃,换手率分别为2596.24%、111.03%、15.37%,振幅较大的相关个股有Check-Cap Ltd.、Ispecimen Inc.、Genedx Holdings Corp C/Wts 22/07/2026 ,振幅分别为83.95%、63.16%、52.80%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225050033abdb5ef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225050033abdb5ef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2512822254","title":"Bioaffinity Technologies, Inc.盘中异动 快速拉升6.37%报0.836美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512822254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512822254?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:01","pubTimestamp":1739984492,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时01分,Bioaffinity Technologies, Inc.股票出现波动,股价急速拉升6.37%。截至发稿,该股报0.836美元/股,成交量2.3907万股,换手率0.15%,振幅4.11%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为0.93%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220010133988b49a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220010133988b49a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2510886349","title":"Bioaffinity Technologies, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510886349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510886349?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:30","pubTimestamp":1739197857,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时30分,Bioaffinity Technologies, Inc.股票出现异动,股价大幅上涨5.13%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为0.00%。其相关个股中,安奈特保险、Prenetics Global、Precipio, Inc.涨幅较大,Inotiv, Inc.、Mainz Biomed N.V.、Neuronetics, Inc.较为活跃,换手率分别为0.42%、0.41%、0.25%,振幅较大的相关个股有Inotiv, Inc.、Bioaffinity Technologies, Inc.、Neogenomics, Inc.,振幅分别为7.98%、2.46%、1.67%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223057988077ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223057988077ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2509645744","title":"Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509645744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509645744?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:35","pubTimestamp":1738938938,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时35分,Bioaffinity Technologies, Inc.股票出现波动,股价大幅下挫5.95%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为1.06%。其相关个股中,梅特勒-托利多、Exagen Inc.、Prophase Labs, Inc.涨幅较大,Neuronetics, Inc.、Guardant Health, Inc.、Mainz Biomed N.V.较为活跃,换手率分别为4.46%、1.56%、1.24%,振幅较大的相关个股有安奈特保险、Neuronetics, Inc.、T2 Biosystems, Inc.,振幅分别为9.11%、7.02%、5.76%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223538abc62b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223538abc62b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0},{"id":"2509002207","title":"Bioaffinity Technologies, Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509002207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509002207?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:40","pubTimestamp":1738867223,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时40分,Bioaffinity Technologies, Inc.股票出现波动,股价急速跳水5.51%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体跌幅为1.24%。其相关个股中,Genedx Holdings Corp C/Wts 22/07/2026 、Neuronetics, Inc.、Endra Life Sciences Inc.涨幅较大,Ispecimen Inc.、Mainz Biomed N.V.、T2 Biosystems, Inc.较为活跃,换手率分别为15.09%、13.74%、4.16%,振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Mainz Biomed N.V.、Prophase Labs, Inc.,振幅分别为25.50%、14.00%、13.63%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207024023a23c0113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207024023a23c0113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2509235744","title":"Bioaffinity Technologies, Inc.盘中异动 早盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509235744?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:19","pubTimestamp":1738772391,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时19分,Bioaffinity Technologies, Inc.股票出现波动,股价大幅上涨5.04%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中,整体涨幅为0.16%。其相关个股中,Grail, Inc.、Exagen Inc.、Prophase Labs, Inc.涨幅较大,Mainz Biomed N.V.、Genedx Holdings Corp.、Ispecimen Inc.较为活跃,换手率分别为15.90%、10.69%、3.64%,振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Genedx Holdings Corp.、Exagen Inc.,振幅分别为22.77%、21.91%、21.70%。Bioaffinity Technologies, Inc.公司简介:bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600195196191bda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600195196191bda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioaffinitytech.com;ir.bioaffinitytech.com","stockEarnings":[{"period":"1week","weight":-0.2913},{"period":"1month","weight":-0.3233},{"period":"3month","weight":-0.5833},{"period":"6month","weight":-0.8929},{"period":"1year","weight":-0.9615},{"period":"ytd","weight":-0.2373}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"bioAffinity Technologies, Inc.于2014年3月26日在特拉华州成立。该公司专注于早期癌症和肺部疾病的无创诊断需求,并靶向癌症治疗。该公司开发了体外诊断专有平台,其第一个平台是用于早期发现肺癌的无创检测。该公司的诊断测试基于可能适用于检测其他肺部疾病如慢性阻塞性肺病(COPD)和哮喘,以及诊断前列腺癌和膀胱癌等癌症类型的平台技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.125018},{"month":2,"riseRate":0.25,"avgChangeRate":-0.105874},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.165848},{"month":4,"riseRate":1,"avgChangeRate":0.35077},{"month":5,"riseRate":0,"avgChangeRate":-0.162067},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.024762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.072762},{"month":8,"riseRate":0,"avgChangeRate":-0.216971},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.17769},{"month":10,"riseRate":0.25,"avgChangeRate":-0.105345},{"month":11,"riseRate":0.25,"avgChangeRate":-0.068737},{"month":12,"riseRate":0,"avgChangeRate":-0.246482}],"exchange":"NASDAQ","name":"bioAffinity Technologies, Inc.","nameEN":"bioAffinity Technologies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"bioAffinity Technologies, Inc.(BIAF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供bioAffinity Technologies, Inc.(BIAF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"bioAffinity Technologies, Inc.,BIAF,bioAffinity Technologies, Inc.股票,bioAffinity Technologies, Inc.股票老虎,bioAffinity Technologies, Inc.股票老虎国际,bioAffinity Technologies, Inc.行情,bioAffinity Technologies, Inc.股票行情,bioAffinity Technologies, Inc.股价,bioAffinity Technologies, Inc.股市,bioAffinity Technologies, Inc.股票价格,bioAffinity Technologies, Inc.股票交易,bioAffinity Technologies, Inc.股票购买,bioAffinity Technologies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"bioAffinity Technologies, Inc.(BIAF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供bioAffinity Technologies, Inc.(BIAF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}